Prevalence of ineffective esophageal motility and its relevance to symptoms and esophageal acid exposure in Korean patients referred for foregut symptoms

被引:9
|
作者
Lee, Kwang Jae [1 ]
Kim, Jin Hong [1 ]
Cho, Sung Won [1 ]
机构
[1] Ajou Univ, Sch Med, Dept Gastroenterol, Suwon 441749, South Korea
关键词
erosive reflux esophagitis; esophageal acid exposure; gastroesophageal reflux disease; ineffective esophageal motility;
D O I
10.1159/000094525
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims:The prevalence and clinical significance of ineffective esophageal motility (IEM) in a population with low prevalence of gastroesophageal reflux disease are not known. Our aim was to investigate the prevalence and its relevance to symptoms and esophageal acid exposure in Korean patients referred for foregut symptoms. Methods: A total of 112 consecutive patients who underwent esophageal manometry, 24-hour esophageal pH monitoring and endoscopy for foregut symptoms were analyzed. IEM was defined as > 20% of wet swallows with amplitudes of < 30 mm Hg or lack of peristalsis. Results: IEM and abnormal acid exposure were observed in respectively 29 and 19% of all subjects. The prevalence of individual symptoms did not differ between IEM and non-IEM groups. Hypotensive lower esophageal sphincter (LES) was significantly more prevalent in IEM patients. The prevalence of abnormal acid exposure in IEM and non-IEM groups was comparable. The prevalence of IEM was similar between patients with and without abnormal acid exposure. Erosive reflux esophagitis was significantly more prevalent in IEM patients compared with non-IEM patients. Conclusion: IEM is not a significant marker for a specific symptom or abnormal acid exposure. However, the presence of IEM is associated with a higher prevalence of hypotensive LES and erosive reflux esophagitis. Copyright (c) 2006 S. Karger AG, Basel.
引用
收藏
页码:171 / 177
页数:7
相关论文
共 26 条
  • [21] Impact of CYP2C19 metabolizer status on esophageal mucosal inflammation, acid exposure, and motility among patients on chronic proton-pump inhibitor therapy with refractory symptoms of gastroesophageal reflux disease
    Tai, Cheng-Chun
    Medwid, Samantha
    McIntosh, Keith
    Chande, Nilesh
    Kim, Richard B.
    Gregor, James
    JOURNAL OF THE CANADIAN ASSOCIATION OF GASTROENTEROLOGY, 2024, 7 (03) : 238 - 245
  • [22] Can symptoms predict esophageal motor function or acid exposure in gastroesophageal reflux disease? - A comparison of esophageal manometric and twenty-four-hour pH parameters in typical and extraesophageal gastroesophageal reflux disease
    DiBaise, JK
    Quigley, EMM
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2001, 32 (02) : 128 - 132
  • [23] Prevalence of gastro-esophageal reflux disease in patients with difficult to control asthma and effect of proton pump inhibitor therapy on asthma symptoms, reflux symptoms, pulmonary function and requirement for asthma medications
    Sandur, V
    Murugesh, M.
    Banait, V
    Rathi, P. M.
    Bhatia, S. J.
    Joshi, J. M.
    Kate, A.
    JOURNAL OF POSTGRADUATE MEDICINE, 2014, 60 (03) : 282 - 286
  • [24] A more than 10-year prospective, follow-up study of esophageal and pharyngeal acid exposure, symptoms and laryngeal findings in healthy, asymptomatic volunteers
    Andersson, Olle
    Moller, Riitta Ylitalo
    Finizia, Caterina
    Ruth, Magnus
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2009, 44 (01) : 23 - 31
  • [25] The value of ambulatory 24 hr esophageal pH monitoring in clinical practice in patients who were referred with persistent gastroesophageal reflux disease (GERD)-related symptoms while on standard dose anti-reflux medications
    Bautista, JM
    Wong, WM
    Pulliam, G
    Esquivel, RF
    Fass, R
    DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (10) : 1909 - 1915
  • [26] The Value of Ambulatory 24 hr Esophageal pH Monitoring in Clinical Practice in Patients Who Were Referred with Persistent Gastroesophageal Reflux Disease (GERD)-Related Symptoms While on Standard Dose Anti-Reflux Medications
    Jimmy M. Bautista
    Wai-man Wong
    Gloria Pulliam
    Romeo F. Esquivel
    Ronnie Fass
    Digestive Diseases and Sciences, 2005, 50 : 1909 - 1915